Sym004, a novel strategy to target EGFR with an antibody mixture, in patients with advanced SCCHN progressing after anti-EGFR monoclonal antibody: A proof of concept study.
暂无分享，去创建一个
J. Machiels | T. Gauler | A. Dietz | R. Knecht | U. Keilholz | I. Horak | M. Henke | J. Krauss | P. Specenier | Y. Lalami | M. Kaminsky | N. Skartved | M. Flensburg